| Active Ingridient | Pazopanib Hydrochloride |
| Brand | Votrient |
| Country of origin | India |
| Form | Oral Tablet |
Votrient Tablet is an antineoplastic drug that contains the active ingredient Pazopanib hydrochloride. It belongs to a drug class called tyrosine kinase inhibitors (TKIs) used for treating kidney cancer and soft tissue sarcoma.
Always use this medicine as prescribed by your doctor. The benefits of this medicine may show in a few weeks or months, so do not stop taking it unless your doctor advises you to stop.
Clinical Uses
Votrient Tablet is used in adults to treat advanced kidney cancer. It is also used to treat soft tissue sarcoma, a type of cancer that affects the supportive tissues of the body. This medicine treats cancer by stopping the activities of proteins responsible for the growth and spread of cancer cells.
Dose Options
Votrient Tablet is available in the following dose strengths: 200 mg and 400 mg. The dose will be determined by the doctor depending on the type and severity of the condition.
How It Works
Votrient tablet is an anticancer medicine. It works by inhibiting specific proteins called tyrosine kinases, which are responsible for sending signals to cancer cells to grow and multiply. It also stops the growth of new blood vessels within the tumor. By blocking these signals, Votrient Tablet fights against cancerous cells.
Side Effects
Side effects of Votrient Tablet include:
- Diarrhea
- Vomiting
- Nausea
- Fatigue
- Blurred vision
- Chest pain
- Dizziness
- Fever
- Hair loss
- Itching
- Skin rash
- Stomach pain or tenderness
Visit your doctor if you experience any side effects or usual symptoms, to manage them before they worsen.
Precautions & Warnings
- Alcohol consumption is not recommended while taking Votrient Tablet as it may increase the risk of side effects.
- Votrient Tablet is not safe during pregnancy. It can cause serious effects leading to birth defects or pregnancy loss. Inform your doctor if you are pregnant or planning to conceive.
- Breastfeeding women should not use Votrient Tablet as it can pass toxicity to the baby through breast milk.
- Patients with liver or kidney disease must use this medicine with caution. In severe kidney disease, this medicine should be avoided.
- Votrient Tablet is not recommended for use in children below 18 years.
- This medicine is not advised to be used in patients with heart problems.
- Votrient Tablet can make you feel dizzy or decrease your visibility, so it is not advised to drive during this medication.
Drug Interactions
Votrient Tablet can interact with the following medications:
- Erythromycin
- Ketoconazole
- Phenytoin
- Hydrocodone
- Yellow fever vaccine
- Azithromycin
- Chloramphenicol
- Esomeprazole
- Hydroxycholoquine
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
